Article Data

  • Views 652
  • Dowloads 144

Original Research

Open Access

Correlation of diaphragm surgical findings with preoperative CT scans in ovarian cancer

  • A. Pereira1,*,
  • J. F. Magrina2
  • P. M. Magtibay2
  • N. I. Bassiouni2
  • T. Cuesta-Guardiola2
  • P. Magtibay III2
  • H. E. Kosiorek3
  • T. Perez-Medina1

1Department of Gynecology Oncology (A.P.,T.P-M.) Puerta de Hierro University Hospital Madrid. Autonoma University of Madrid (Spain)

2Division of Gynecologic Surgery (J.F.M., N.I.B., T.C-G., P.M.III, P.M.M.) Mayo Clinic, Arizona (USA)

3Division of Health Sciences Research (H.E.K.), Mayo Clinic Arizona, Scottsdale, Arizona (USA)

DOI: 10.31083/j.ejgo.2020.01.5032 Vol.41,Issue 1,February 2020 pp.75-79

Published: 15 February 2020

*Corresponding Author(s): A. Pereira E-mail:


Objective: Correlation of diaphragm surgical findings in ovarian cancer patients with and without diaphragm metastases with pre-operative CT diaphragm findings to assess sensitivity and specificity for diaphragm disease. Material and Methods: A retrospective study of 120 ovarian cancer patients (60 with and 60 without diaphragm metastases at surgery), FIGO Stage IIIC or IV, undergoing cytoreductive surgery at Mayo Clinic, Arizona, between January 2000 and October 2014. All patients had preoperative imaging with CT scan of abdomen and pelvis including the lower lung fields. CTs were not reviewed retrospectively. Results: Among 60 patients with diaphragm metastases, preoperative CTs were positive for diaphragm disease in 17 patients, with a sensitivity rate of 28% (CI 95%: 0.17- 0.41). All 60 patients with no diaphragm metastases had negative CTs, with a specificity of 100% (CI 95%: 94.0%-100%). When analyzed by lesion size, CTs were negative in 66.7-80% of patients with diaphragm lesions ranging from 1-15 mm. There was a trend towards increased detection rate with increasing size of lesions, but it did not reach significance (p = 0.529). CT detection rate for single metastatic lesion was 18.2% (6/33) and for multiple lesions it was 25.9% (7/27). There was no difference for CT identification of right, left, or bilateral metastases (p = 0.399). The sensitivity and specificity of CT for pleural effusion was 100% (CI 95%: 72.2%-100%) and 88% (CI 95%: 76.2%- 94.4%), respectively. The area under the receiver operating characteristic (ROC) curve was 0.680 (CI 95%: 55.3%-72.2%) for CT detection of diaphragm metastases and 0.957 (CI 95%: 79.9%-95.3%) for pleural effusions. Conclusion: CT has a low sensitivity and a high specificity for the prediction of diaphragm metastases in ovarian cancer. The size, location, and number of diaphragm lesions do not significantly improve CT detection rate.


Ovarian cancer; Diaphragm; CT scan.

Cite and Share

A. Pereira,J. F. Magrina,P. M. Magtibay,N. I. Bassiouni,T. Cuesta-Guardiola,P. Magtibay III,H. E. Kosiorek,T. Perez-Medina. Correlation of diaphragm surgical findings with preoperative CT scans in ovarian cancer. European Journal of Gynaecological Oncology. 2020. 41(1);75-79.


[1] Fanfani F., Fagotti A., Gallota V., Ercoli A., Pacelli F., Constantini B., et al.: “Upper abdominal surgery in advanced and recurrent ovarian cancer: Role of diaphragmatic surgery. Gynecol Oncol. 2010 Mar;116:497-501.

[2] Nougaret S., Addley H.C., Colombo P.E., Fujii S., Al Sharif S.S., Tirumani S.H., Jardon K., Sala E., Reinhold C.: “Ovarian carcinomatosis: how the radiologist can help plan the surgical approach”. Radiographics, 2012, 32, 1775.

[3] Aletti G.D., Dowdy S.C., Gostout B.S., Jones M.B., Stanhope C.R., Wilson T.O., et al.: “Aggressive surgical effort and improved survival in advanced-stage ovarian cancer”. Obstet. Gynecol., 2006, 107, 77.

[4] Tsolakidis D., Amant F., Van Gorp T., Leunen K., Neven P., Vergote I.: “Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancer”. Gynecol. Oncol., 2010, 116, 489.

[5] Eisenhauer E.L., Abu-Rustum N.R., Sonoda Y., Levine D.A., Poynor E.A., Aghajanian C., et al.: “The addition of extensive upper abdominal surgery to achive optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer”. Gynecol. Oncol., 2006, 103, 1083.

[6] Dowdy S.C., Mullany S.A., Brand K.R., Huppert B.J., Cliby W.A.: “The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma”. Cancer, 2004, 101, 346.

[7] Jung D.C., Kang S., Kang M.J., Park S.Y., Kim H.B.: “Multidetector CT predictors of incomplete resection in primary cytoreduction of patients with advanced ovarian cancer”. Eur. Radiol., 2010, 20, 100.

[8] Glaser G., Torres M., Kim B., Aletti G., Weaver A., Mariani A., et al.: “The use of CT findings to predict extent of tumor at primary surgery for ovarian cancer”. Gynecol. Oncol., 2013, 130, 280.

[9] Meyer J.I., Kennedy A.W., Friedman R., Ayoub A., Zepp R.C.: “Ovarian Carcinoma: value of CT in predicting success of debulking surgery”. Am. J. Roentgenol., 1995, 165, 875.

[10] Eisenkop S., Spirtos N.: “What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer”. Gynecol. Oncol., 2008, 108, 287.

[11] Pannu H.K., Bristow R.E., Montz F.J., Fishman E.K.: “Multidetector CT of peritoneal carcinomatosis from ovarian cancer”. Radiographics, 2003, 23, 687.

[12] Funicelli L., Travaini L.L., Landoni F., Trifiro G., Bonello L., Bellomi M.: “Peritoneal carcinomatosis from ovarian cancer: the role of CT and [18F]FDG-PET/CT”. Abdom. Imaging, 2010, 35, 701.

[13] Kyriazi S., Kaye S.B., deSouza N.M.: “Imaging ovarian cancer and peritoneal metastases—current and emerging techniques”. Nat. Rev. Clin. Oncol., 2010, 7, 381.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time